VALIANT LABORATORIES
|
VALIANT LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | |
---|---|
Operational & Financial Ratios | |
Earnings Per Share (Rs) | 8.91 |
CEPS(Rs) | 9.39 |
DPS(Rs) | - |
Book NAV/Share(Rs) | 30.86 |
Tax Rate(%) | 23.96 |
Margin Ratios | |
Core EBITDA Margin(%) | 10.51 |
EBIT Margin(%) | 11.50 |
Pre Tax Margin(%) | 11.42 |
PAT Margin (%) | 8.68 |
Cash Profit Margin (%) | 9.15 |
Performance Ratios | |
ROA(%) | 13.62 |
ROE(%) | 28.86 |
ROCE(%) | 24.01 |
Asset Turnover(x) | 1.57 |
Sales/Fixed Asset(x) | 5.04 |
Working Capital/Sales(x) | 3.34 |
Efficiency Ratios | |
Fixed Capital/Sales(x) | 0.20 |
Receivable days | 96.81 |
Inventory Days | 14.26 |
Payable days | 62.43 |
Valuation Parameters | |
PER(x) | - |
PCE(x) | - |
Price/Book(x) | - |
Yield(%) | - |
EV/Net Sales(x) | 0.27 |
EV/Core EBITDA(x) | 2.27 |
EV/EBIT(x) | 2.36 |
EV/CE(x) | 0.43 |
M Cap / Sales | - |
Growth Ratio | |
Net Sales Growth(%) | - |
Core EBITDA Growth(%) | - |
EBIT Growth(%) | - |
PAT Growth(%) | - |
EPS Growth(%) | - |
Financial Stability Ratios | |
Total Debt/Equity(x) | 0.59 |
Current Ratio(x) | 2.97 |
Quick Ratio(x) | 2.71 |
Interest Cover(x) | 151.14 |
Total Debt/Mcap(x) | - |
Compare Financial Ratios of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹616.1 Cr | -4.8% | -14.1% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹366,354.0 Cr | 2.3% | -0.8% | 60.8% | Stock Analytics | |
CIPLA | ₹113,516.0 Cr | 3.5% | 0.7% | 43.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,352.0 Cr | 2.7% | 3% | 17.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,367.0 Cr | 3.1% | 3.8% | 91.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,961.5 Cr | -0.1% | -3.5% | 29.5% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -4.8% |
-14.1% |
|
SENSEX | -0.7% |
-2.7% |
17.8% |
You may also like the below Video Courses